AB027. SOH26AB_0416. Is contrast-enhanced mammography or breast MRI superior in assessing treatment response in patients with breast cancer following neoadjuvant chemotherapy?—an evidence-based approach
Mesentery and Peritoneum · 2026-04 · 10 · AB027-AB027
DOI: 10.21037/map-26-ab027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mesentery and Peritoneum, 2026-04. Verfasst von Mary Byrne und 1 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Byrne, M., & Brennan, C. (2026). AB027. SOH26AB_0416. Is contrast-enhanced mammography or breast MRI superior in assessing treatment response in patients with breast cancer following neoadjuvant chemotherapy?—an evidence-based approach. Mesentery and Peritoneum, 10, AB027-AB027. https://doi.org/10.21037/map-26-ab027
Vancouver
Byrne M, Brennan C. AB027. SOH26AB_0416. Is contrast-enhanced mammography or breast MRI superior in assessing treatment response in patients with breast cancer following neoadjuvant chemotherapy?—an evidence-based approach. Mesentery and Peritoneum. 2026;10:AB027-AB027. doi:10.21037/map-26-ab027
BibTeX
@article{Byrne2026,
author = {Byrne, Mary and Brennan, Cressida},
title = {AB027. SOH26AB_0416. Is contrast-enhanced mammography or breast MRI superior in assessing treatment response in patients with breast cancer following neoadjuvant chemotherapy?—an evidence-based approach},
journal = {Mesentery and Peritoneum},
year = {2026},
volume = {10},
pages = {AB027--AB027},
doi = {10.21037/map-26-ab027}
}
EUVIMED